Key Data Points

Primary metrics and data points about Galectin Therapeutics Inc..
Current Price: $1.17
Prev Close: $1.20
Open: $1.25
Bid: $1.15
Ask: $1.85
Day's Range: $1.17 - $1.25
52wk Range: $1.17 - $4.40
Volume: 76,657
Avg Vol 120,311
Market Cap: $28.00M
P/E (ttm): -1.38
EPS (ttm): -$0.87
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Galectin Therapeutics Inc..

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GALT vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Galectin Therapeutics Inc..
CAPS Rating 1 out of 5
 
49 Outperform
42 Underperform
CAPS All Stars
 
6 Outperform
28 Underperform

Powered by Motley Fool CAPS


More Details about Galectin Therapeutics Inc.

Primary metrics and data points about Galectin Therapeutics Inc..